In vitro Anti-Cancer Activity of Rosuvastatin and Ketorolac Nanoformulations against DDX3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vitro Anti-Cancer Activity of Rosuvastatin and Ketorolac Nanoformulations against DDX3

Published:2017-10-10 Issue:4 Volume:9 Page:537-544
ISSN:0975-1483
Container-title:Journal of Young Pharmacists
language:
Short-container-title:JYP

Author:

Bheemanapally Khaggeswar,Thimmaraju Manish Kumar,Kasagoni Sagar,Thatikonda Prathyusha,Akula Swathi,Kodamala Kranthi Raj,Kakarla Lavanya,Gummadi Sridhar Babu,Nemani Harishankar,Botlagunta Mahendran

Publisher

EManuscript Technologies

Subject

General Pharmacology, Toxicology and Pharmaceutics

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:—an in silico and in vitro approach;Medical Oncology;2022-09-01

2. FORMULATION, EVALUATION AND CYTOTOXIC POTENTIAL OF METRONIDAZOLE LOADED POLOXAMER 407 HYDROGEL IN SCC-29 CELL LINES;INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH;2019-03-01

3. Comparative in vitro and in silico characterization of anticancer compounds piceatannol, biochanin-A and resveratrol on breast cancer cells;Pharmacognosy Magazine;2019

4. Fabrication of rosuvastatin-loaded polymeric nanocapsules: a promising modality for treating hepatic cancer delineated by apoptotic and cell cycle arrest assessment;Drug Development and Industrial Pharmacy;2018-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP